This month, Amsterdam-based food technology startup Meatable announced it has raised $10 million in a seed funding round, bringing its total funding to $13 million to date, led in part by the European Commission. The company will use the funds to further its mission of creating real pork through cellular agriculture. Meatable’s proprietary technology OPTI-OX—which is built on the foundation of Nobel Prize-winning research and optimized by Stanford and Cambridge scientists—uses only one animal cell to produce meat in a short period of time, solving the scalability issue of cell-based meat production. “We believe no one should have to give up the meat they love—there is a way to satisfy the world’s appetite for meat without harming people, animals, or the planet,” Meatable CEO and co-founder Krijn de Nood said. Meatable participated in the Eurostars-2 program where the company received a Eureka label, a classification reserved for companies poised to make a global impact. “Our mission is to become the leading choice for sustainably and efficiently produced meat. To achieve that mission, we will need to solve the cultivated meat industry’s scale-up challenge. We hope that the unveiling of our first prototype this summer will show that we are making real strides toward fulfilling our mission.” In 2013, Mark Post—vascular physiology professor at Maastricht University in the Netherlands and chief scientific officer at cell-based company Mosa Meat—unveiled the first cultured-meat burger, which then cost approximately $325,000 to create. Since, companies around the world are working to create cheaper, slaughter-free versions of beef, chicken, pork, and fish. In October, California startup JUST put a cruelty-free spin on answering the age-old question: “Which came first? The chicken or the egg?” when, after perfecting the vegan JUST Egg, it announced that its cell-based chicken was ready for small-scale commercialization at $50 per nugget.
Subscribe now to the world’s #1